Professor Salome Charalambous

And by the beginning of next year, some of these trials will start being reported.

And we are, the community, the TB community at the moment, we're working very hard, working with governments to ready them and prepare governments for if the vaccine does come out to be effective.

People are really optimistic that the new vaccines are going to show a benefit because the phase two trials did show benefit.

And so we think there's a good chance.

But of course, we can't be sure until the results come out fully and we're aware.

So that is something that we're looking forward to.

Yes.

But you have to have those steps.

If we don't do the phase three trial, we won't have a vaccine at all.

So we have to do that.

We have to go through these steps and then eventually get to the point where we will be now talking about

all the people who don't want to take the vaccine and why and how to fix that and so on.

But hopefully we're trying as much as possible to make sure that the countries are as ready as they can be when we do get a vaccine so that it can actually be a smooth rollout and as many people as possible can receive the vaccine and then be protected.

So we are hoping that that's going to be the case.

experience with funding gaps or if any recent um you know reductions in usaid have if you've experienced that in your own work of course very much so so um in our in our organization we had a usaid grant that was providing some services to communities um we had spent a year

to get the grant up and running.

And it required that we would have a memorandum of understandings with the provinces that we were going to be working in.

Of course, makes sense.

You know, they want to understand what you're going to be doing.

How are you going to, how are you, how